Cemtrex (CETX) had the highest return between 2004 and 2008 by a US stock, returning 136,634,732.9%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Cemtrex (CETX) | 2004-2008 | 136,634,732.93% |
Future Fintech (FTFT) | 2004-2008 | 4,651,062.79% |
India Globalization Capital (IGC) | 2004-2008 | 1,616,566.67% |
National Grid PLC ADR (NGG) | 2004-2008 | 1,018,952.94% |
Enveric Biosciences (ENVB) | 2004-2008 | 978,160.97% |
Natwest (NWG) | 2004-2008 | 953,400% |
Taoping (TAOP) | 2004-2008 | 863,957.6% |
Northern Oil & Gas (NOG) | 2004-2008 | 838,607.69% |
Know Labs (KNW) | 2004-2008 | 534,224.43% |
Alto Ingredients (ALTO) | 2004-2008 | 210,858.9% |
Ring Energy (REI) | 2004-2008 | 146,566.67% |
OPTIMIZERx (OPRX) | 2004-2008 | 124,100% |
Ocean Power Technologies (OPTT) | 2004-2008 | 74,233.33% |
Perspective Therapeutics (CATX) | 2004-2008 | 66,566.67% |
Lixte Biotechnology (LIXT) | 2004-2008 | 55,965.57% |
PharmaCyte Biotech (PMCB) | 2004-2008 | 12,988.89% |
NanoViricides (NNVC) | 2004-2008 | 11,240% |
Gyre Therapeutics (GYRE) | 2004-2008 | 7,448.45% |
Universal Insurance (UVE) | 2004-2008 | 6,311.31% |
Cryoport (CYRX) | 2004-2008 | 5,997.3% |
Gulf Resources (GURE) | 2004-2008 | 5,900% |
Broadwind Energy (BWEN) | 2004-2008 | 5,300.22% |
Champions Oncology (CSBR) | 2004-2008 | 5,300% |
Oramed Pharmaceuticals (ORMP) | 2004-2008 | 3,134.28% |
Monster Beverage (MNST) | 2004-2008 | 3,086.09% |
